Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-01 Dier Mardi CFO & Executive Vice President Grant or award · Stock Option (Right to Buy) +11,000 11,000
2021-03-01 Bedrosian Camille L EVP and Chief Medical Officer Grant or award +5,500 39,046
2021-03-01 Bedrosian Camille L EVP and Chief Medical Officer Grant or award +4,636 43,682
2021-03-01 Bedrosian Camille L EVP and Chief Medical Officer Sale −4,543 $138.18 $628K 39,139
2021-03-01 Bedrosian Camille L EVP and Chief Medical Officer Grant or award · Stock Option (Right o Buy) +11,000 11,000
2021-03-01 KAKKIS EMIL D President & CEO Grant or award +18,000 596,941
2021-03-01 KAKKIS EMIL D President & CEO Grant or award +15,453 612,394
2021-03-01 KAKKIS EMIL D President & CEO Shares withheld for taxes −16,342 $142.47 $2.3M 596,052
2021-03-01 KAKKIS EMIL D President & CEO Sale −30,000 $141.80 $4.3M 2,289,741
2021-03-01 KAKKIS EMIL D President & CEO Grant or award · Stock Option (Right to Buy) +36,000 36,000
2021-02-23 Aliski William Director Gift −1,000 64,704
2021-02-19 Aliski William Director Exercise or conversion +7,500 $97.85 $734K 73,204
2021-02-19 Aliski William Director Sale −7,500 $149.01 $1.1M 65,704
2021-02-19 Aliski William Director Exercise or conversion · Stock Option (Right to Buy) −7,500 0
2021-01-30 Bedrosian Camille L EVP and Chief Medical Officer Sale −2,243 $140.36 $315K 33,546
2021-01-15 Bedrosian Camille L EVP and Chief Medical Officer Exercise or conversion +25,000 $55.00 $1.4M 60,789
2021-01-15 Bedrosian Camille L EVP and Chief Medical Officer Sale −25,000 $139.18 $3.5M 35,789
2021-01-15 Bedrosian Camille L EVP and Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −25,000 63,000
2021-01-07 Huizenga Theodore Alan SVP, Controller and PAO Exercise or conversion +4,000 $21.00 $84K 20,436
2021-01-07 Huizenga Theodore Alan SVP, Controller and PAO Sale −4,000 $140.65 $563K 15,716

Page 22 of 32 · 632 trades